Literature DB >> 28338977

Effects of Augmenting N-Methyl-D-Aspartate Receptor Signaling on Working Memory and Experience-Dependent Plasticity in Schizophrenia: An Exploratory Study Using Acute d-cycloserine.

Jennifer K Forsyth1, Peter Bachman2, Daniel H Mathalon3,4, Brian J Roach4, Elissa Ye1, Robert F Asarnow1,5.   

Abstract

Cognitive deficits in schizophrenia have been hypothesized to reflect N-methyl-D-aspartate receptor (NMDAR) dysfunction. However, the mechanisms through which the NMDAR contributes to individual cognitive functions differ. To explore how NMDAR signaling relates to specific cognitive deficits in schizophrenia, we tested the effects of enhancing NMDAR signaling on working memory and experience-dependent plasticity using d-cycloserine (DCS). Plasticity was assessed using an EEG paradigm that utilizes high-frequency visual stimulation (HFvS) to induce neural potentiation, and 2 learning tasks, the information integration (IIT) and weather prediction (WPT) tasks. Working memory was assessed using an N-back task. Forty-five schizophrenia patients were randomized to receive a single 100 mg DCS dose (SZ-DCS; n = 24) or placebo (SZ-PLC; n = 21) in a double-blind, between-groups design. Testing occurred on a single day after placebo or DCS administration; baseline values were not obtained. DCS did not affect plasticity, as indicated by similar neural potentiation, and similar IIT and WPT learning between groups. However, among patients who successfully engaged in the working memory task (ie, performed above chance), SZ-DCS (n = 17) showed superior 2-back performance compared to SZ-PLC (n = 16). Interestingly, SZ-DCS also showed larger pre-HFvS neural responses during the LTP task. Notably, this pattern of DCS effects is the opposite of those found in our prior study of healthy adults. Results are consistent with target engagement of the NMDAR by DCS, but suggest that NMDAR signaling was not translated into synaptic plasticity changes in schizophrenia. Results highlight the importance of considering how distinct NMDAR-associated processes contribute to individual cognitive deficits in schizophrenia.
© The Author 2017. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  NMDA receptor; cognition; learning; long-term potentiation; memory; psychosis

Mesh:

Substances:

Year:  2017        PMID: 28338977      PMCID: PMC5581900          DOI: 10.1093/schbul/sbw193

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  72 in total

1.  Habit and skill learning in schizophrenia: evidence of normal striatal processing with abnormal cortical input.

Authors:  Thomas W Weickert; Alejandro Terrazas; Llewellyn B Bigelow; James D Malley; Thomas Hyde; Michael F Egan; Daniel R Weinberger; Terry E Goldberg
Journal:  Learn Mem       Date:  2002 Nov-Dec       Impact factor: 2.460

2.  Long-term potentiation (LTP) of human sensory-evoked potentials.

Authors:  Ian J Kirk; Nicolas A McNair; Jeffrey P Hamm; Wesley C Clapp; Daniel H Mathalon; Idil Cavus; Timothy J Teyler
Journal:  Wiley Interdiscip Rev Cogn Sci       Date:  2010-07-27

3.  Acute, but not chronic, exposure to d-cycloserine facilitates extinction and modulates spontaneous recovery of a conditioned taste aversion.

Authors:  G Andrew Mickley; Jennifer L Remus; Linnet Ramos; Gina N Wilson; Orion R Biesan; Kyle D Ketchesin
Journal:  Physiol Behav       Date:  2011-09-10

4.  Subcortical visual dysfunction in schizophrenia drives secondary cortical impairments.

Authors:  Pamela D Butler; Antigona Martinez; John J Foxe; Dongsoo Kim; Vance Zemon; Gail Silipo; Jeannette Mahoney; Marina Shpaner; Maria Jalbrzikowski; Daniel C Javitt
Journal:  Brain       Date:  2006-09-19       Impact factor: 13.501

5.  Stability and course of neuropsychological deficits in schizophrenia.

Authors:  R K Heaton; J A Gladsjo; B W Palmer; J Kuck; T D Marcotte; D V Jeste
Journal:  Arch Gen Psychiatry       Date:  2001-01

Review 6.  Should schizophrenia be treated as a neurocognitive disorder?

Authors:  M F Green; K H Nuechterlein
Journal:  Schizophr Bull       Date:  1999       Impact factor: 9.306

7.  Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-D-aspartate receptor.

Authors:  G Henderson; J W Johnson; P Ascher
Journal:  J Physiol       Date:  1990-11       Impact factor: 5.182

8.  Acute but not chronic activation of the NMDA-coupled glycine receptor with D-cycloserine facilitates learning and retention.

Authors:  D Quartermain; J Mower; M F Rafferty; R L Herting; T H Lanthorn
Journal:  Eur J Pharmacol       Date:  1994-05-12       Impact factor: 4.432

9.  Decreased expression of NMDA receptor-associated proteins in frontal cortex of elderly patients with schizophrenia.

Authors:  Adam J Funk; Gavin Rumbaugh; Vahram Harotunian; Robert E McCullumsmith; James H Meador-Woodruff
Journal:  Neuroreport       Date:  2009-07-15       Impact factor: 1.837

10.  Biological insights from 108 schizophrenia-associated genetic loci.

Authors: 
Journal:  Nature       Date:  2014-07-22       Impact factor: 49.962

View more
  9 in total

Review 1.  Auditory System Target Engagement During Plasticity-Based Interventions in Schizophrenia: A Focus on Modulation of N-Methyl-D-Aspartate-Type Glutamate Receptor Function.

Authors:  Joshua T Kantrowitz; Neal R Swerdlow; Walter Dunn; Sophia Vinogradov
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-02-22

Review 2.  Mapping the Consequences of Impaired Synaptic Plasticity in Schizophrenia through Development: An Integrative Model for Diverse Clinical Features.

Authors:  Jennifer K Forsyth; David A Lewis
Journal:  Trends Cogn Sci       Date:  2017-07-25       Impact factor: 20.229

3.  Efficacy of adjunctive D-Cycloserine for the treatment of schizophrenia: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Pooja Patnaik Kuppili; Vikas Menon; Gopinath Sathyanarayanan; Siddharth Sarkar; Chittaranjan Andrade
Journal:  J Neural Transm (Vienna)       Date:  2021-01-13       Impact factor: 3.575

4.  Evaluating visual neuroplasticity with EEG in schizophrenia outpatients.

Authors:  Jonathan K Wynn; Brian J Roach; Amanda McCleery; Stephen R Marder; Daniel H Mathalon; Michael F Green
Journal:  Schizophr Res       Date:  2019-08-19       Impact factor: 4.939

5.  Visual cortical plasticity and the risk for psychosis: An interim analysis of the North American Prodrome Longitudinal Study.

Authors:  Michael S Jacob; Brian J Roach; Holly K Hamilton; Ricardo E Carrión; Aysenil Belger; Erica Duncan; Jason Johannesen; Matcheri Keshavan; Sandra Loo; Margaret Niznikiewicz; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; William Stone; Ming Tsuang; Elaine F Walker; Scott W Woods; Daniel H Mathalon
Journal:  Schizophr Res       Date:  2021-03-02       Impact factor: 4.939

6.  Effects of neuroactive metabolites of the tryptophan pathway on working memory and cortical thickness in schizophrenia.

Authors:  Junchao Huang; Jinghui Tong; Ping Zhang; Yanfang Zhou; Yimin Cui; Shuping Tan; Zhiren Wang; Fude Yang; Peter Kochunov; Joshua Chiappelli; Baopeng Tian; Li Tian; Yunlong Tan; L Elliot Hong
Journal:  Transl Psychiatry       Date:  2021-04-01       Impact factor: 6.222

7.  Multimodal Neuroimaging Study of Visual Plasticity in Schizophrenia.

Authors:  S Andrea Wijtenburg; Jeffrey West; Stephanie A Korenic; Franchesca Kuhney; Frank E Gaston; Hongji Chen; Laura M Rowland
Journal:  Front Psychiatry       Date:  2021-04-01       Impact factor: 4.157

Review 8.  Drugs Based on NMDAR Hypofunction Hypothesis in Schizophrenia.

Authors:  Qiongqiong Wu; Jing Huang; Renrong Wu
Journal:  Front Neurosci       Date:  2021-04-12       Impact factor: 4.677

9.  Loosening of Associations in Chronic Schizophrenia: Intersectionality of Verbal Learning, Negative Symptoms, and Brain Structure.

Authors:  Paul G Nestor; James J Levitt; Toshiyuki Ohtani; Dominick T Newell; Martha E Shenton; Margaret Niznikiewicz
Journal:  Schizophr Bull Open       Date:  2022-03-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.